Edenred SE (EDNMF)

Theseus Pharmaceuticals Revenue

Edenred SE had revenue of 1.34B EUR in the half year ending June 30, 2025, with 23.87% growth. This brings the company's revenue in the last twelve months to 2.68B, up 7.04% year-over-year. In the year 2024, Edenred SE had annual revenue of 2.61B with 12.89% growth.

• Revenue (ttm): 2.68B EUR
• Revenue Growth: +7.04%
• P/S Ratio: 2.31
• Revenue / Employee: 217.29K EUR
• Employees: 12,320
• Market Cap: 7.26B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.61B	298.00M	12.89%
Dec 31, 2023	2.31B	367.00M	18.88%
Dec 31, 2022	1.94B	361.00M	22.80%
Dec 31, 2021	1.58B	160.00M	11.24%
Dec 31, 2020	1.42B	-147.00M	-9.36%